Skip to main content
Important notice

Warning – Fraudulent Calls

Several persons have received fraudulent calls impersonating RAMQ. If you do not have a pending request with us or if the call seems suspicious, do not provide any personal information. Make a note of the agent’s name, end the conversation and call us. To find out more, refer to Our communication practices webpage.

Notice of alternative medication authorization, December 22, 2023

Legal publication
Updated on

 30 January 2024

This notice was published on January 30, 2024.

VictozaTM liraglutide (rupture) and TrulicityTM dulaglutide (rupture) and Semaglutide replace Semaglutide (Ozempic).